Live webinar recording: Making NIPT accessible to all women

Although the utilization of NIPT is becoming more commonplace, there are still many barriers that women face that prevent global uptake. This webinar aims to address some of the obstacles that have prevented the widescale adoption of NIPT. Issues such as: cost, focus, precision and ease of use will all be examined by our speakers and then reevaluated using PerkinElmer’s new Vanadis® NIPT platform.

Detailed program
  • Cost-effective screening: has NIPT lost its focus?
    Howard Cuckle, PhD, Faculty of Medicine, Tel Aviv University, Israel
  • Importance of precision in achieving the goals of NIPT
    Fredrik Persson, PhD, Sr. Principal Scientist, Vanadis Diagnostics, a PerkinElmer company
  • Ease of use: ensuring global accessibility
    Alka Chaubey, PhD, FACMG, Head of Cytogenomics and Laboratory Director, PerkinElmer Global Genomic Laboratories, USA
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.

Watch the Webinar

Required only for US and Canada